How Lipitor Lowers Cholesterol
Lipitor (atorvastatin) is a statin drug that reduces low-density lipoprotein (LDL) cholesterol, often called "bad" cholesterol, by inhibiting HMG-CoA reductase, a liver enzyme essential for cholesterol synthesis. This enzyme converts HMG-CoA into mevalonate, a precursor to cholesterol. By blocking it, Lipitor cuts the liver's cholesterol production by up to 50% at higher doses.[1][2]
The liver responds by increasing LDL receptors on its surface. These receptors bind LDL particles from the blood and pull them into cells for breakdown, clearing LDL from circulation. Studies show Lipitor lowers LDL by 35-60%, depending on dose (10-80 mg daily).[1][3]
What Happens to Other Lipids
Lipitor also modestly raises high-density lipoprotein (HDL, "good" cholesterol) by 5-15% and lowers triglycerides by 20-40%. These effects stem from reduced liver cholesterol output, which shifts lipid metabolism.[1][2]
How Long Until It Works
Blood LDL drops within 2 weeks of starting Lipitor, with maximum effect by 4-6 weeks. Full benefits require consistent use, as cholesterol synthesis rebounds if stopped.[3]
Why It Doesn't Affect All Cholesterol Types Equally
Lipitor targets liver-made cholesterol (70% of total) more than dietary sources. It pairs well with diet and exercise for broader control.[1]
Common Side Effects Patients Report
Muscle pain (myalgia) affects 5-10% of users, rarely progressing to rhabdomyolysis. Liver enzyme elevations occur in 1-3%; monitoring is standard. Risk rises with high doses or drug interactions like fibrates.[2][3]
Who Makes Lipitor and When Did Patents Expire
Pfizer developed Lipitor, approved by FDA in 1996. Key U.S. patents expired in 2011, allowing generics (also atorvastatin) to enter, dropping prices 80-90%.[4] For patent details, see DrugPatentWatch.com.
Sources
[1] FDA Label: Lipitor
[2] NEJM: Statin Mechanism Review (1998)
[3] AHA Guidelines on Cholesterol Management
[4] DrugPatentWatch: Lipitor